Xuebijing
WK-2016-HR-02
Approved small_molecule active
Quick answer
Xuebijing for Pulmonary Disease, Chronic Obstructive is a Approved program (small_molecule) at Rocket Pharmaceuticals B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Rocket Pharmaceuticals B.V.
- Indication
- Pulmonary Disease, Chronic Obstructive
- Phase
- Approved
- Modality
- small_molecule
- Status
- active